Detalhe da pesquisa
1.
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
N Engl J Med
; 379(8): 722-730, 2018 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30134131
2.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29863979
3.
Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
Value Health
; 24(3): 377-387, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641772
4.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952975
5.
Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(11): 1465-1477, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961119
6.
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res
; 25(19): 5961-5971, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399473
7.
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
Future Oncol
; 16(4): 11-19, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31951149
8.
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.
Future Oncol
; 16(28): 2165-2175, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723187
9.
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.
World J Surg
; 44(4): 1283-1293, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811340
10.
Management of intussusception in patients with melanoma.
J Surg Oncol
; 119(7): 897-902, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30734297
11.
Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAF V600E-Mutant Melanoma.
Clin Cancer Res
; 24(22): 5516-5524, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674508
12.
Development of Targeted Alpha Particle Therapy for Solid Tumors.
Molecules
; 24(23)2019 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31779154
13.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Cancer
; 124(22): 4332-4341, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303516
14.
Malignant adnexal tumors of the skin: a single institution experience.
World J Surg Oncol
; 16(1): 99, 2018 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848318
15.
Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.
J Natl Compr Canc Netw
; 15(4): 473-482, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404758
16.
The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.
Clin Cancer Res
; 21(3): 561-8, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424850
17.
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 16(4): 375-84, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795410
18.
Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection.
J Surg Oncol
; 111(7): 829-33, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772798
19.
Echoes of a failure: what lessons can we learn?
Lancet Oncol
; 20(8): 1037-1039, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31221617
20.
Melanoma, version 4.2014.
J Natl Compr Canc Netw
; 12(5): 621-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24812131